Evidence map›Paper›PMID 28877911›Full record

ArticleDiabetes2017

Hepatic GALE Regulates Whole-Body Glucose Homeostasis by Modulating

Yi Zhu, Shangang Zhao, Yingfeng Deng, Ruth Gordillo, Alexandra L Ghaben, Mengle Shao, Fang Zhang, Ping Xu, Yang Li, Huachuan Cao and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 52 citations in OpenAlex.

  1. ADAR RNA editing for cardiovascular disease: TargetingMolecular therapy. Nucleic acids · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biomolecules & therapeutics · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis.Liver international : official journal of the International Association for the Study of the Liver · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Yi ZhuLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN.
Shangang ZhaoTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Yingfeng DengTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Ruth GordilloTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Alexandra L GhabenTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Mengle ShaoTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Fang ZhangTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Ping XuLilly China Research and Development Center, Shanghai, China.
Yang LiLilly China Research and Development Center, Shanghai, China.
Huachuan CaoLilly China Research and Development Center, Shanghai, China.
Olga ZagnitkoSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
David A ScottSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Rana K GuptaTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX.
Chao XingMcDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX.
Bei B ZhangLilly China Research and Development Center, Shanghai, China.
Hua V LinLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN philipp.scherer@utsouthwestern.edu lin_hua@lilly.com.
Philipp E SchererTouchstone Diabetes Center, UT Southwestern Medical Center, Dallas, TX philipp.scherer@utsouthwestern.edu lin_hua@lilly.com.ORCID 0000-0002-5336-1358
Southwestern Medical Center · USLilly (China) · CNEli Lilly (United States) · USSanford Burnham Prebys Medical Discovery Institute · USChinese Academy of Sciences · CN

Funding

The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Novel Mechanisms Regulating the Adipocyte-Brain-Hepatocyte AxisP01DK088761 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI SCHERER, PHILIPP E · 2010 to 2019
$17.4M
Adiponectin, A Protein Secreted From Adipose TissueR01DK055758 · NIDDK · YESHIVA UNIVERSITY · PI SCHERER, PHILIPP E · 2000 to 2024
$10.9M
White Adipose Tissue Physiology, Mitochondrial Function and AdiponectinR01DK099110 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PHILIPP E SCHERER · 2013 to 2026
$6.7M
Establishment and Maintenance of Healthy Adipose Tissue in ObesityR01DK104789 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI GUPTA, RANA K · 2015 to 2024
$3.9M
NCATS NIH HHS UL1 TR001105NIA NIH HHS P01 AG051459NIDDK NIH HHS P01 DK088761NIDDK NIH HHS R01 DK055758NIDDK NIH HHS R01 DK099110NIDDK NIH HHS R01 DK104789
6 · The paper itself

Abstract

Transcripts of key enzymes in the Leloir pathway of galactose metabolism in mouse livers are significantly increased after chronic high-fat/high-sucrose feeding. UDP-galactose-4-epimerase (GALE) is the last enzyme in this pathway that converts UDP-galactose to UDP-glucose and was previously identified as a downstream target of the endoplasmic reticulum (ER) stress effector spliced X-box binding protein 1, suggesting an interesting cross talk between galactose and glucose metabolism in the context of hepatic ER stress and whole-body metabolic fitness. However, its specific role in glucose metabolism is not established. Using an inducible and tissue-specific mouse model, we report that hepatic overexpression of

Indexed as

AnimalsEndoplasmic ReticulumGene Expression Regulation, EnzymologicGlucoseHomeostasisLiverMiceMice, TransgenicTrefoil Factor-3UDPglucose 4-EpimeraseGlucoseTff3 protein, mouseTrefoil Factor-3UDPglucose 4-Epimerase

Identifiers

PMID28877911
PMCPMC5652600
OpenAlexW2752114290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.